Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Medical Imaging
  4. Volume 20, Issue 1
  5. Article
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603
file format pdf download PDF
side by side viewer icon HTML

Abstract

Objective

To analyze the MRI findings of stage IA ovarian cancer.

Methods

The data on age distribution, clinical symptoms at onset, CA125 detection, MRI findings, including tumor volume, structure, diffusion-weighted imaging (DWI), apparent diffusion coefficient (ADC) and enhancement, , of the patients with stage IA ovarian cancer, who were admitted to Nantong tumor Hospital between 2013 and 2020 were analyzed retrospectively.

Results

Only 11 cases of stage IA ovarian cancer were recorded. The age of patients was 30–67 (average 52) years. The initial symptoms were mostly lower abdominal distension and abdominal pain. CA125 was 90% positive. MRI features 1. Large pelvic mass with a volume range of 23–2,009 cm3 (average 669 cm3). 2. Five cases of cyst type (with plaque-like, papillary, or mural nodule vegetations), two cases of cystic-solid mixed type (with thickened septum or wall), and four cases of solid type. 3. DWI diffusion was limited, and ADC was reduced on all solid components (vegetation, septa, and cyst wall). 4. The solid parts were significantly enhanced on T1-enhanced MRI. 5. There was no metastasis in the pelvic cavity, and a few ascites (negative tumor cells) in three patients.

Conclusion

MRI characteristics of stage IA ovarian carcinomas were large tumors; cystic, cystic-solid, or solid; solid parts limited diffusion on DWI and low ADC; enhancement of the cyst wall, vegetation, and septa; no pelvic metastasis.

© 2024 The Author(s). Published by Bentham Open.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmir/10.2174/1573405619666230306102912
2024-01-01
2024-11-23

  • From This Site

    /content/journals/cmir/10.2174/1573405619666230306102912
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cmir/20/1/CMIM-20-e060323214362.html?itemId=/content/journals/cmir/10.2174/1573405619666230306102912&mimeType=html&fmt=ahah

References

  1. TorreL.A. TrabertB. DeSantisC.E. MillerK.D. SamimiG. RunowiczC.D. GaudetM.M. JemalA. SiegelR.L. Ovarian cancer statistics, 2018.CA Cancer J. Clin.201868428429610.3322/caac.2145629809280
     [Google Scholar]
  2. ShaabanA. RezvaniM. Ovarian cancer: detection and radiologic staging.Clin. Obstet. Gynecol.2009521739310.1097/GRF.0b013e318196162519179862
     [Google Scholar]
  3. JavadiS. GaneshanD.M. QayyumA. IyerR.B. BhosaleP. Ovarian cancer, the revised FIGO staging system, and the role of imaging.AJR Am. J. Roentgenol.201620661351136010.2214/AJR.15.1519927042752
     [Google Scholar]
  4. SmithR.A. AndrewsK.S. BrooksD. FedewaS.A. Manassaram-BaptisteD. SaslowD. BrawleyO.W. WenderR.C. Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening.CA Cancer J. Clin.201868429731610.3322/caac.2144629846940
     [Google Scholar]
  5. ParkS.B. LeeJ.B. MRI features of ovarian cystic lesions.J. Magn. Reson. Imaging201440350351510.1002/jmri.2457924474469
     [Google Scholar]
  6. LiS. LiuJ. XiongY. PangP. LeiP. ZouH. ZhangM. FanB. LuoP. A radiomics approach for automated diagnosis of ovarian neoplasm malignancy in computed tomography.Sci. Rep.2021111873010.1038/s41598‑021‑87775‑x33888749
     [Google Scholar]
  7. JeongY.Y. OutwaterE.K. KangH.K. Imaging evaluation of ovarian masses.Radiographics20002051445147010.1148/radiographics.20.5.g00se10144510992033
     [Google Scholar]
  8. CastellaniF. NgangaE.C. DumasL. BanerjeeS. RockallA.G. Imaging in the pre-operative staging of ovarian cancer.Abdom. Radiol. (N.Y.)201944268569610.1007/s00261‑018‑1779‑630229424
     [Google Scholar]
  9. ForstnerR. Early detection of ovarian cancer.Eur. Radiol.202030105370537310.1007/s00330‑020‑06937‑z32468105
     [Google Scholar]
  10. ShenZ.Y. ShenA.J. YangS.L. WuM.F. Combination of sonographic morphology score and tumor markers for detecting postoperative recurrent pelvic ovarian carcinoma.Ultrasound Q.2019351455310.1097/RUQ.000000000000039430672869
     [Google Scholar]
  11. HricakH. ChenM. CoakleyF.V. KinkelK. YuK.K. SicaG. BacchettiP. PowellC.B. Complex adnexal masses: Detection and characterization with MR imaging--multivariate analysis.Radiology20002141394610.1148/radiology.214.1.r00ja393910644099
     [Google Scholar]
  12. ArmstrongD.K. AlvarezR.D. BackesF.J. Bakkum-GamezJ.N. BarroilhetL. BehbakhtK. BerchuckA. ChenL. ChitiyoV.C. CristeaM. DeRosaM. EisenhauerE.L. GershensonD.M. GrayH.J. GrishamR. HakamA. JainA. KaramA. KonecnyG.E. LeathC.A.III LeiserowitzG. LiuJ. MartinL. MateiD. McHaleM. McLeanK. MillerD.S. Percac-LimaS. RemmengaS.W. SchorgeJ. StewartD. ThakerP.H. VargasR. HendricksonA.W. WernerT.L. ZsirosE. DwyerM.A. HangL. NCCN Guidelines® insights: Ovarian cancer, version 3.2022.J. Natl. Compr. Canc. Netw.202220997298010.6004/jnccn.2022.004736075393
     [Google Scholar]
  13. MorganR.J.Jr AlvarezR.D. ArmstrongD.K. BurgerR.A. ChenL. CopelandL. CrispensM.A. GershensonD.M. GrayH.J. HakamA. HavrileskyL.J. JohnstonC. LeleS. MartinL. MatulonisU.A. O’MalleyD.M. PensonR.T. PowellM.A. RemmengaS.W. SabbatiniP. SantosoJ.T. SchinkJ.C. TengN. WernerT.L. DwyerM.A. HughesM. Ovarian cancer, version 2.2013.J. Natl. Compr. Canc. Netw.201311101199120910.6004/jnccn.2013.014224142821
     [Google Scholar]
  14. MorganR.J.Jr ArmstrongD.K. AlvarezR.D. Bakkum-GamezJ.N. BehbakhtK. ChenL. CopelandL. CrispensM.A. DeRosaM. DorigoO. GershensonD.M. GrayH.J. HakamA. HavrileskyL.J. JohnstonC. LeleS. MartinL. MatulonisU.A. O’MalleyD.M. PensonR.T. Percac-LimaS. PinedaM. PlaxeS.C. PowellM.A. RatnerE. RemmengaS.W. RoseP.G. SabbatiniP. SantosoJ.T. WernerT.L. BurnsJ. HughesM. Ovarian Cancer, Version 1.2016, NCCN clinical practice guidelines in oncology.J. Natl. Compr. Canc. Netw.20161491134116310.6004/jnccn.2016.012227587625
     [Google Scholar]
  15. BillmireD.F. CullenJ.W. RescorlaF.J. DavisM. SchlatterM.G. OlsonT.A. MalogolowkinM.H. PashankarF. VillalunaD. KrailoM. EglerR.A. Rodriguez-GalindoC. FrazierA.L. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: Report from the Children’s Oncology Group.J. Clin. Oncol.201432546547010.1200/JCO.2013.51.100624395845
     [Google Scholar]
  16. ArmstrongD.K. AlvarezR.D. Bakkum-GamezJ.N. BarroilhetL. BehbakhtK. BerchuckA. ChenL. CristeaM. DeRosaM. EisenhauerE.L. GershensonD.M. GrayH.J. GrishamR. HakamA. JainA. KaramA. KonecnyG.E. LeathC.A. LiuJ. MahdiH. MartinL. MateiD. McHaleM. McLeanK. MillerD.S. O’MalleyD.M. Percac-LimaS. RatnerE. RemmengaS.W. VargasR. WernerT.L. ZsirosE. BurnsJ.L. EnghA.M. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.J. Natl. Compr. Canc. Netw.202119219122610.6004/jnccn.2021.000733545690
     [Google Scholar]
  17. MatulonisU.A. SoodA.K. FallowfieldL. HowittB.E. SehouliJ. KarlanB.Y. Ovarian cancer.Nat. Rev. Dis. Primers2016211606110.1038/nrdp.2016.6127558151
     [Google Scholar]
  18. OltG.J. BerchuckA. BastR.C.Jr Gynecologic tumor markers.Semin. Surg. Oncol.19906630531310.1002/ssu.29800606042263805
     [Google Scholar]
  19. TürkoğluS. KayanM. Differentiation between benign and malignant ovarian masses using multiparametric MRI.Diagn. Interv. Imaging2020101314715510.1016/j.diii.2020.01.00631987805
     [Google Scholar]
  20. ZhangS. YuS. HouW. LiX. NingC. WuY. ZhangF. JiaoY.F. LeeL.T.O. SunL. Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors.J. Ovarian Res.20191218710.1186/s13048‑019‑0568‑331526390
     [Google Scholar]
  21. SteinE.B. RoselandM.E. ShampainK.L. WasnikA.P. MaturenK.E. Contemporary Guidelines for Adnexal Mass Imaging: A 2020 Update.Abdom. Radiol. (N.Y.)20214652127213910.1007/s00261‑020‑02812‑z33079254
     [Google Scholar]
  22. TaylorE.C. IrshaidL. MathurM. Multimodality imaging approach to ovarian neoplasms with pathologic correlation.Radiographics202141128931510.1148/rg.202120008633186060
     [Google Scholar]
  23. ParkS.Y. OhY.T. JungD.C. Differentiation between borderline and benign ovarian tumors: combined analysis of MRI with tumor markers for large cystic masses (≥5 cm).Acta Radiol.201657563363910.1177/028418511559726626231948
     [Google Scholar]
  24. ZhuangY. WangT. ZhangG. Diffusion-Weighted Magnetic Resonance Imaging (DWI) parameters in benign and malignant ovarian tumors with solid and cystic components.J. Coll. Physicians Surg. Pak.201929210510810.29271/jcpsp.2019.02.10530700345
     [Google Scholar]
  25. BentC.L. SahdevA. RockallA.G. SinghN. SohaibS.A. ReznekR.H. MRI appearances of borderline ovarian tumours.Clin. Radiol.200964443043810.1016/j.crad.2008.09.01119264189
     [Google Scholar]
  26. ZillioxM. LecointreL. AzaisH. BallesterM. BendifallahS. BolzeP.A. BourdelN. BricouA. CanlorbeG. CarcopinoX. ChauvetP. CollinetP. CoutantC. DabiY. DionL. GauthierT. GraesslinO. HuchonC. KoskasM. LavoueV. MezzadriM. MimounC. OuldamerL. RaimondE. TouboulC. LapointeM. AkladiosC. Management of borderline ovarian tumours during pregnancy: Results of a French multi-centre study.Eur. J. Obstet. Gynecol. Reprod. Biol.202125641241810.1016/j.ejogrb.2020.11.03333296755
     [Google Scholar]
  27. GünakanE. TohmaY.A. KarakaşL.A. AkıllıH. HaberalA.N. AyhanA. Prognostic impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer.Obstet. Gynecol. Sci.202063446446910.5468/ogs.1920432550735
     [Google Scholar]
  28. Eymerit-MorinC. BrunJ.L. VabretO. Devouassoux-ShisheboranM. Borderline ovarian tumours: CNGOF Guidelines for clinical practice-Biopathology of ovarian borderline tumors.Gynécol. Obstét. Fertil. Sénol.202048962964510.1016/j.gofs.2020.05.00732422414
     [Google Scholar]
  29. LeeK.R. CastrillonD.H. NucciM.R. Pathologic findings in eight cases of ovarian serous borderline tumors, three with foci of serous carcinoma, that preceded death or morbidity from invasive carcinoma.Int. J. Gynecol. Pathol.200120432933410.1097/00004347‑200110000‑0000311603215
     [Google Scholar]
  30. JungH.J. ParkJ.Y. KimD.Y. SuhD.S. KimJ.H. KimY.M. KimY.T. NamJ.H. Low value of staging in detecting extraovarian occult metastasis in mucinous borderline ovarian tumors.Int. J. Gynecol. Cancer202030111780178310.1136/ijgc‑2020‑00135532928923
     [Google Scholar]
  31. GammonR. HameedA. Keyhani-RofaghaS. Peritoneal washing in borderline epithelial ovarian tumors in women under 25: The use of cell block preparations.Diagn. Cytopathol.199818321221410.1002/(SICI)1097‑0339(199803)18:3<212::AID‑DC10>3.0.CO;2‑N9523141
     [Google Scholar]
  32. WongH.F. LowJ.J.H. ChuaY. BusmanisI. TayE.H. HoT.H. Ovarian tumors of borderline malignancy: A review of 247 patients from 1991 to 2004.Int. J. Gynecol. Cancer200717234234910.1111/j.1525‑1438.2007.00864.x17343573
     [Google Scholar]
  33. DaraïE. TulpinL. PrugnolleH. CortezA. DubernardG. Laparoscopic restaging of borderline ovarian tumors.Surg. Endosc.200721112039204310.1007/s00464‑007‑9286‑917514402
     [Google Scholar]
  34. deSouzaN.M. O’NeillR. McIndoeG.A. DinaR. SoutterW.P. Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease.AJR Am. J. Roentgenol.20051843999100310.2214/ajr.184.3.0184099915728632
     [Google Scholar]
  35. SteinE.B. WasnikA.P. SciallisA.P. KamayaA. MaturenK.E. MR imaging–pathologic correlation in ovarian cancer.Magn. Reson. Imaging Clin. N. Am.201725354556210.1016/j.mric.2017.03.00428668159
     [Google Scholar]
  36. BolisG. ScarfoneG. RaspagliesiF. MangiliG. DaneseS. ScolloP. RussoD.L. VillaA. AimoneP.D. ScambiaG. Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III–IV epithelial ovarian cancer a multicenter, randomized study.Eur. J. Cancer201046162905291210.1016/j.ejca.2010.06.12420673626
     [Google Scholar]
  37. FlicekK.T. VanBurenW. DudiakK. LahkmanY. ChenL.W. ButlerK. MeniasC.O. Borderline epithelial ovarian tumors: What the radiologist should know.Abdom. Radiol. (N.Y.)20214662350236610.1007/s00261‑020‑02688‑z32860524
     [Google Scholar]
  38. MukudaN. IshibashiM. MurakamiA. FukunagaT. FujiiS. Ovarian solid tumors: MR imaging features with radiologic–pathologic correlation.Jpn. J. Radiol.202038871973010.1007/s11604‑020‑00976‑832342277
     [Google Scholar]
  39. TomaoF. Di PintoA. SassuC.M. Di DonatoV. MuziiL. PetrellaM.C. PeccatoriF.A. Benedetti PaniciP. PaniciP.B. Fertility preservation in ovarian tumours.Ecancermedicalscience20181288510.3332/ecancer.2018.88530679952
     [Google Scholar]
  40. TrimbosJ.B. Surgical treatment of early-stage ovarian cancer.Best Pract. Res. Clin. Obstet. Gynaecol.201741607010.1016/j.bpobgyn.2016.10.00127894705
     [Google Scholar]
  41. CraneE.K. BrownJ. Early stage mucinous ovarian cancer: A review.Gynecol. Oncol.2018149359860410.1016/j.ygyno.2018.01.03529429591
     [Google Scholar]
/content/journals/cmir/10.2174/1573405619666230306102912
Loading
MRI Appearances of Stage IA Ovarian Carcinoma
Curr. Med. Imaging 20, E060323214362 (2024); https://doi.org/10.2174/1573405619666230306102912
/content/journals/cmir/10.2174/1573405619666230306102912
/content/journals/cmir/10.2174/1573405619666230306102912
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Apparent diffusion coefficient; CA125; Diffusion-weighted imaging; MRI; Ovarian carcinoma; Stage IA

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test